ENSCW Ensysce Biosciences, Inc.
Fundamentals / CIK 0001716947 / USDEnsysce Biosciences, Inc. reported $6.19M in revenue and a net loss of $91.21M for the trailing twelve months ended September 30, 2026 (up 342.4% year over year), with a -1477.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENSCW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$6.19M +342.4% YoY
-
Operating Income TTM-$91.42M -1477.0% margin
-
Net Income TTM-$91.21M -1473.7% net margin
-
Diluted EPS TTM-$5.01 Split-adjusted
-
Free Cash Flow TTM-$7.93M -128.1% FCF margin
-
Cash & ST Investments Sep 30, 2026$29.67M Total debt: --
Annual revenue and net income
8 fiscal years (2018 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.07M | $5.21M | $2.23M | $2.52M | $3.53M | $3.93M | -- | -- |
| Research & Development | $10.38M | $7.22M | $7.59M | $19.84M | $4.69M | $4.39M | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | $18.71M | $1.15M | -- | -- |
| Total Operating Expenses | $15.31M | $11.94M | $12.95M | $26.75M | $23.40M | $5.54M | $3.33M | $1.56M |
| Operating Income | -$10.24M | -$6.73M | -$10.72M | -$24.22M | -$19.87M | -$1.61M | -$3.33M | -$959K |
| EBITDA | -$10.23M | -$6.73M | -$10.72M | -$24.22M | -$19.87M | -$1.61M | -- | -- |
| Interest Income | -- | -- | -- | -- | -- | $720K | $4.25M | $3.63M |
| Interest Expense | $19K | $1.29M | $354K | $110K | $1.30M | $995K | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -- | $2.65M | $921K | $2.68M |
| Income Tax Expense | -- | -- | -- | -- | -- | $244K | $555K | $554K |
| Net Income | -$10.18M | -$7.99M | -$10.63M | -$25.09M | -$29.89M | $2.40M | $366K | $2.12M |
| Basic EPS | -$3.98 | -$11.45 | -$70.40 | -$2,091.30 | -$1,270,794.03 | $0.00 | -$403,018.35 | -$188,646.89 |
| Diluted EPS | -$3.98 | -$11.45 | -$70.40 | -$2,091.30 | -$1,269,079.06 | $0.00 | -$403,018.35 | -$188,646.89 |
| Basic Shares Outstanding | 2.6M | 697.7K | 150.9K | 12.0K | 24 | 18 | 7 | 7 |
| Diluted Shares Outstanding | 2.6M | 697.7K | 150.9K | 12.0K | 24 | 19 | 7 | 7 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18M | $1.16M | $961K | $1.88M | $493K | $1.37M | $1.32M | $1.30M |
| Research & Development | $3.18M | $2.47M | $3.35M | $3.61M | $2.95M | $1.92M | $1.89M | $3.80M |
| Total Operating Expenses | $84.68M | $3.74M | $4.52M | $4.66M | $4.23M | $3.12M | $3.29M | $4.88M |
| Operating Income | -$82.50M | -$2.58M | -$3.56M | -$2.78M | -$3.74M | -$1.75M | -$1.97M | -$3.58M |
| EBITDA | -$82.49M | -$2.57M | -$3.56M | -$2.78M | -$3.74M | -$1.75M | -$1.97M | -$3.58M |
| Interest Expense | $3.1K | $320 | $3.9K | $5.4K | $6.4K | $3.2K | $3.9K | $11K |
| Net Income | -$82.32M | -$2.57M | -$3.56M | -$2.77M | -$3.73M | -$1.73M | -$1.95M | -$3.56M |
| Basic EPS | -$4.52 | -$0.20 | -$0.52 | -- | -$1.29 | -$0.79 | -$1.39 | -- |
| Diluted EPS | -$4.52 | -$0.20 | -$0.52 | -- | -$1.29 | -$0.79 | -$1.39 | -- |
| Basic Shares Outstanding | 18.2M | 13.0M | 6.8M | -- | 2.9M | 2.2M | 1.4M | -- |
| Diluted Shares Outstanding | 18.2M | 13.0M | 6.8M | -- | 2.9M | 2.2M | 1.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.31M | $3.50M | $1.12M | $3.15M | $12.26M | $194K | $1.06M | $1.66M | $2.09M |
| Cash & Short-Term Investments | $4.31M | $3.50M | $1.12M | $3.15M | $12.26M | $194K | $1.06M | $1.66M | $2.09M |
| Other Current Assets | $21K | $18K | $18K | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $7.25M | $5.34M | $2.29M | $5.30M | $15.66M | $348K | $1.20M | $1.92M | $2.31M |
| Property, Plant & Equipment, Net | $124K | -- | -- | -- | -- | $151 | -- | -- | -- |
| Other Non-Current Assets | $83K | $253K | $419K | $586K | $755K | $3.8K | -- | -- | -- |
| Total Non-Current Assets | $207K | $253K | $419K | $586K | $755K | $3.9K | $195.3M | $202.9M | $200.1M |
| Total Assets | $7.45M | $5.60M | $2.71M | $5.89M | $16.42M | $352K | $196.5M | $204.8M | $202.4M |
| Accounts Payable | $3.27M | $1.36M | $1.94M | $2.94M | $301K | $1.72M | $2.77M | $429K | $112K |
| Total Current Liabilities | $4.57M | $2.21M | $3.33M | $9.46M | $16.48M | $7.01M | $2.77M | $438K | $156K |
| Other Non-Current Liabilities | -- | $10K | $26K | $310K | $3.65M | -- | -- | -- | -- |
| Total Non-Current Liabilities | $0 | $10K | $26K | $450K | $8.09M | $0 | $7.57M | $7.00M | $7.00M |
| Total Liabilities | $4.57M | $2.22M | $3.36M | $9.91M | $24.58M | $7.01M | $10.34M | $7.44M | $7.16M |
| Total Debt (incl. Leases) | -- | -- | -- | $27K | $25K | $26K | -- | -- | -- |
| Common Stock | $459 | $136 | $21 | $53 | $124 | $1.6K | $638 | $604 | $673 |
| Retained Earnings | -$139.7M | -$129.5M | -$121.6M | -$110.9M | -$85.85M | -$55.96M | $2.46M | $2.09M | -$31K |
| Total Stockholders' Equity | $3.21M | $3.71M | -$323K | -$3.71M | -$7.88M | -$6.44M | $5.00M | $5.00M | $5.00M |
| Total Equity | $2.88M | $3.38M | -$651K | -$4.03M | -$8.16M | -$6.66M | -$6.68M | $5.00M | $5.00M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $29.67M | $677K | $745K | $4.31M | $1.67M | $2.21M | $3.05M | $3.50M |
| Cash & Short-Term Investments | $29.67M | $677K | $745K | $4.31M | $1.67M | $2.21M | $3.05M | $3.50M |
| Other Current Assets | $28K | $21K | $26K | $21K | $68K | $241K | $223K | $18K |
| Total Current Assets | $30.80M | $2.85M | $2.01M | $7.25M | $2.93M | $5.28M | $4.40M | $5.34M |
| Property, Plant & Equipment, Net | $156K | $111K | $118K | $124K | $124K | -- | -- | -- |
| Other Non-Current Assets | -- | -- | $42K | $83K | $128K | $293K | $211K | $253K |
| Total Non-Current Assets | $156K | $111K | $159K | $207K | $251K | $293K | $211K | $253K |
| Total Assets | $30.95M | $2.96M | $2.17M | $7.45M | $3.18M | $5.57M | $4.61M | $5.60M |
| Accounts Payable | $2.03M | $1.98M | $1.61M | $3.27M | $463K | $1.04M | $615K | $1.36M |
| Total Current Liabilities | $3.84M | $4.07M | $2.84M | $4.57M | $2.30M | $2.51M | $1.76M | $2.21M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $35 | $1.0K | $130K | $10K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $35 | $1.0K | $130K | $10K |
| Total Liabilities | $3.84M | $4.07M | $2.84M | $4.57M | $2.30M | $2.51M | $1.89M | $2.22M |
| Common Stock | $1.9K | $1.6K | $929 | $459 | $320 | $241 | $165 | $136 |
| Retained Earnings | -$228.0M | -$145.8M | -$143.3M | -$139.7M | -$137.0M | -$133.2M | -$131.5M | -$129.5M |
| Accumulated Other Comp. Income | -$237K | -- | -- | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $27.44M | -$782K | -$340K | $3.21M | $1.20M | $3.39M | $3.05M | $3.71M |
| Total Equity | $27.11M | -$1.11M | -$669K | $2.88M | $875K | $3.06M | $2.72M | $3.38M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$10.18M | -$7.99M | -$10.63M | -$24.21M | -$29.15M | -$161K | $3.24M | $2.12M |
| Depreciation & Amortization | $6.5K | $0 | $0 | $0 | $151 | $201 | -- | -- |
| Stock-Based Compensation | $177K | $111K | $879K | $1.07M | $122K | $179K | -- | -- |
| Change in Payables | $1.82M | -$579K | -$1.23M | $2.64M | -$1.42M | $1.18M | -- | -- |
| Operating Cash Flow | -$7.81M | -$7.50M | -$10.78M | -$17.89M | -$8.24M | -$1.25M | -$1.42M | -$1.24M |
| Capital Expenditure | -$124K | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow | -$7.93M | -- | -- | -- | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -- | -- | -$1.70M | -$566K | -- |
| Investing Cash Flow | -$124K | -- | -- | $4.5K | -- | $183.4M | $11.85M | $839K |
| Common Stock Issued | -- | -- | -- | -- | $6.63M | -$184.8M | -$11.58M | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -$11.58M | -- |
| Financing Cash Flow | $8.74M | $9.88M | $8.76M | $8.77M | $20.31M | $1.10M | -$11.03M | -$32K |
| Net Change in Cash | $808K | $2.38M | -$2.02M | -$9.12M | $12.07M | -$147K | -$597K | -$432K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$82.11M | -$2.57M | -$3.56M | -$2.77M | -$3.73M | -$1.73M | -$1.95M | -$3.56M |
| Depreciation & Amortization | $6.5K | $6.5K | $6.5K | $6.5K | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $405 | $1.9K | $8.7K | $24K | -$50K | $187K | $16K | $30K |
| Change in Payables | -$457K | $308K | -$1.66M | $2.71M | -$579K | $428K | -$742K | -$521K |
| Operating Cash Flow | -$1.40M | -$1.96M | -$3.50M | -$1.53M | -$1.87M | -$2.71M | -$1.71M | -$764K |
| Financing Cash Flow | $19.24M | $1.89M | -$64K | $4.16M | $1.45M | $1.87M | $1.26M | $113K |
| Net Change in Cash | $28.99M | -$69K | -$3.56M | $2.64M | -$538K | -$841K | -$450K | -$652K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -202.1% | -129.2% | -480.5% | -959.9% | -562.7% | -41.0% | -- | -- |
| Net Profit Margin | -200.8% | -153.3% | -476.4% | -994.1% | -846.4% | 61.2% | -- | -- |
| Return on Equity (ROE) | -316.6% | -215.4% | -- | -- | -- | -- | 7.3% | 42.4% |
| Return on Assets (ROA) | -136.5% | -142.7% | -392.4% | -426.3% | -182.0% | 683.5% | 0.2% | 1.0% |
| Current Ratio | 1.59x | 2.42x | 0.69x | 0.56x | 0.95x | 0.05x | 0.43x | 4.38x |
| Quick Ratio | 0.94x | 1.59x | 0.34x | 0.33x | 0.74x | 0.03x | 0.38x | 3.79x |
| Revenue Growth (YoY) | -2.8% | +133.6% | -11.6% | -28.5% | -10.2% | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -1342.9% | +557.1% | -82.8% | -- |
| 5Y Revenue / Share Growth | -100.0% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -100.0% | -100.0% | -100.0% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1477.0% | -281.3% | -251.4% | -202.1% | -245.9% | -89.7% | -110.1% | -129.2% |
| Net Profit Margin | -1473.7% | -280.5% | -250.4% | -200.8% | -244.5% | -88.8% | -109.5% | -153.3% |
| Return on Equity (ROE) | -332.4% | -- | -- | -316.6% | -911.8% | -194.2% | -223.5% | -215.4% |
| Return on Assets (ROA) | -294.7% | -426.9% | -543.7% | -136.5% | -345.1% | -118.1% | -147.8% | -142.7% |
| Current Ratio | 8.02x | 0.70x | 0.71x | 1.59x | 1.27x | 2.10x | 2.50x | 2.42x |
| Quick Ratio | 7.72x | 0.17x | 0.26x | 0.94x | 0.73x | 0.88x | 1.73x | 1.59x |
| Revenue Growth (YoY) | +342.4% | -15.1% | -27.2% | +44.4% | -85.6% | +654.4% | +331.7% | +153.1% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -680.2% | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -663.5% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -229.0% | -- | -- | -- |